.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

In-person and virtual events just for HCPs

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Treatment of Follicular Lymphoma

EP. 1: The Biology of Follicular Lymphoma

January 18th 2016

EP. 2: Follicular Lymphoma Risk Stratification

January 18th 2016

EP. 3: 'Watch and Wait' Versus Therapy Initiation in Follicular Lymphoma

January 18th 2016

EP. 4: First-Line Therapeutic Options in Follicular Lymphoma

January 18th 2016

EP. 5: Treating Relapsed/Refractory Follicular Lymphoma

January 18th 2016

EP. 6: Monoclonal Antibodies in Follicular Lymphoma

January 18th 2016

EP. 7: The Role of Ibrutinib in Follicular Lymphoma

January 18th 2016

EP. 8: Combining Targeted and Immunotherapeutic Agents in FL

January 18th 2016

EP. 9: Novel Treatment Approaches in Follicular Lymphoma

January 18th 2016

EP. 10: Future Strategies in the Treatment of Follicular Lymphoma

January 18th 2016